From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics ...

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

The Parkinson’s Foundation estimates that 15,000 people here in Wisconsin have Parkinson’s disease, and that number is only ...

In D’Iberville, those battling Parkinson’s Disease are slipping on the gloves and fighting back thanks to SAAD Healthcare’s Rock Steady Boxing classes.

Researchers Identify a Potential Biomarker of Parkinson's Disease Progression Nov. 12 ... are detected in blood once symptoms have started in Lewy's body diseases, ... July 23, 2024 ...

Sharon Osbourne shared an update on Ozzy Osbourne’s battle with Parkinson’s disease before his final show with Black Sabbat ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...

People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...